drugset / Trial / NCT02159976

Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea

NCT02159976

RandomizedParallel-groupOpen-labelTreatment

Summary

1. To compare 10-day sequential therapy and 14-day modified bismuth quadruple therapy and to establish more effective first-line regimen for the eradication of Helicobacter pylori in Korea. 2. To evaluate the effect of H. pylori eradication therapy on the symptom improvement of functional dyspepsia

Timeline

Start
2014-07
Primary completion
2015-05
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg
Subject Bismuth Potassium Citrate Unknown 600 mg
Comparator Clarithromycin Small molecule 500 mg
Comparator Metronidazole Small molecule 500 mg
Subject Pantoprazole Other / unclassified 40 mg
Subject Tetracycline Unknown 1000 mg